NASDAQ:SLGC

SomaLogic Earnings Date, Estimates & Call Transcripts (2022)

$5.18

-0.19 (-3.54%)

(As of 06/24/2022 12:00 AM ET)

Add

Compare

Today's Range: $5.10
▼
$5.45
50-Day Range: $4.27
▼
$7.06
52-Week Range: $4.20
▼
$14.72

Volume: 20.70 million shs
Average Volume: 1.34 million shs
Market Capitalization: $944.26 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.00

Latest Earnings Date: May. 12
Actual EPS (May. 12): -$0.15
Consensus EPS (May. 12): -$0.15

Earnings Per Share Revenue

SLGC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SLGC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

SomaLogic Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2022	1	($0.17)	($0.17)	($0.17)
Q2 2022	1	($0.18)	($0.18)	($0.18)
Q3 2022	1	($0.20)	($0.20)	($0.20)
Q4 2022	1	($0.20)	($0.20)	($0.20)
FY 2022	4	($0.75)	($0.75)		($0.75)

SLGC Earnings Date and Information

SomaLogic last posted its quarterly earnings data on May 12th, 2022. The reported ($0.15) earnings per share for the quarter, hitting the consensus estimate of ($0.15). The business earned $22.98 million during the quarter, compared to the consensus estimate of $23.30 million. SomaLogic has generated $0.00 earnings per share over the last year. Earnings for SomaLogic are expected to decrease in the coming year, from ($0.61) to ($0.68) per share.

SomaLogic Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/12/2022	Q1 2022	($0.15)	($0.15)		($0.28)	$23.30 million	$22.98 million
3/29/2022	Q4 2021	($0.12)	($0.16)	($0.04)	($0.19)	$20.55 million	$22.99 million
11/15/2021	Q3 2021		($0.33)	($0.33)	($0.11)		$19.99 million

SomaLogic Earnings - Frequently Asked Questions

When did SomaLogic announce their last quarterly earnings?: SomaLogic (NASDAQ:SLGC) last announced its quarterly earning data on Thursday, May 12, 2022. Learn more on SLGC's earnings history.
Did SomaLogic beat their earnings estimates last quarter?: In the previous quarter, SomaLogic (NASDAQ:SLGC) reported ($0.15) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.15). Learn more on analysts' earnings estimate vs. SLGC's actual earnings.

How much revenue does SomaLogic generate each year?: SomaLogic (NASDAQ:SLGC) has a recorded annual revenue of $81.63 million.
How much profit does SomaLogic generate each year?: SomaLogic (NASDAQ:SLGC) has a recorded net income of -$87.55 million. SLGC has generated $0.00 earnings per share over the last four quarters.
What is SomaLogic's EPS forecast for next year?: SomaLogic's earnings are expected to decrease from ($0.61) per share to ($0.68) per share in the next year.

This page (NASDAQ:SLGC) was last updated on 6/26/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources